Compare Quest Diagnostics Inc (DGX) vs Peloton Interactive Inc (PTON) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quest Diagnostics Inc vs Peloton Interactive Inc — how do they compare? Quest Diagnostics Inc trades at $237.45 (market cap $26.21B), while Peloton Interactive Inc trades at $5.42 (market cap $2.46B). The key difference: Quest Diagnostics Inc is far larger — about 10.7× Peloton Interactive Inc's market cap, and Quest Diagnostics Inc pays a 1.45% dividend while Peloton Interactive Inc pays none. Which is the better fit depends on your goals.
| DGX | PTON | |
|---|---|---|
Market Cap | $26.21B | $2.46B |
Sector | Health | Consumer Cyclical |
52-Week High | $238.50 | $9.00 |
52-Week Low | $173.49 | $3.71 |
Enterprise Value | $31.97B | $2.96B |
Dividend Yield | 1.45% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Quest Diagnostics (DGX) trades at $237.24, down 0.16% on the day, with a bullish technical signal from moving averages. The company reported strong Q2 2026 earnings, beating estimates with EPS of $3.12 and raising its full-year outlook, driven by robust testing demand. Revenue grew to $11.04B in 2025, with net income of $992M, though margins face pressure from lower-margin deals and rising costs.
The outlook is positive due to raised guidance and AI integration enhancing efficiency, but risks include debt levels and margin compression. Analysts maintain a cautious buy stance with a $249.50 price target, indicating modest upside potential from current levels amid competitive and cost challenges.
Peloton Interactive (PTON) trades at $5.42, down 1.63% today, with a bearish technical signal and negative shareholder equity. The company achieved its first annual net profit in fiscal 2026, with Q4 earnings beating estimates at $0.13 per share. Revenue declined to $2.49 billion in 2025, but net losses narrowed significantly to $119 million. Cash flow turned positive at $335 million, and debt-to-asset ratio improved to 63.18% in 2026. Analyst sentiment is mixed with a 50% buy rating.
Outlook remains cautious due to ongoing revenue declines and high debt, but profitability improvements and cost controls provide a foundation for recovery. Key risks include subscriber losses, competitive pressures, and patent litigation. The stock offers speculative upside if growth stabilizes, but requires careful risk management.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →About Peloton Interactive Inc
Peloton Interactive Inc operates an interactive fitness platform. It operates its business in two reportable segments: Connected Fitness Products and Subscription. Connected Fitness Product revenue consists of sales of bike and tread and related accessories, associated fees for delivery and installation, and extended warranty agreements. Subscription revenue consists of revenue generated from monthly Connected Fitness Subscription and Digital Subscription. The company generates the majority of the revenue from the sale of Connected Fitness Products.
Read more on PTON →
